Outlook Therapeutics Inc (NASDAQ:OTLK)
| 0.4256 Delayed Data As of Dec 08 |  -0.0166 / -3.75%Today’s Change | 0.20 Today|||52-Week Range 2.03 | -60.59% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 5.2M | 3.0M | 3.8M | 3.1M | |
| Depreciation And Amortization | 1.8M | 2.4M | 2.7M | 3.1M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 50.0M | 52.3M | 37.0M | 25.5M | ||
| Research And Development | 38.9M | 33.1M | 23.8M | 18.5M | ||
| Total Operating Expenses | 51.8M | 54.7M | 39.7M | 28.5M | ||
| Non-Operating Expenses | Operating Income | -46.6M | -51.8M | -35.9M | -25.4M | |
| Extraordinary Credit | 0.00 | 0.00 | 3.2M | 1.0M | ||
| Extraordinary Charge | 0.00 | 0.00 | 0.00 | -5.5M | ||
| Interest Expense On Debt | 2.3M | 1.5M | 5.6M | 3.9M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -48.9M | -53.2M | -38.3M | -33.7M | |
| Income Taxes | -190.1K | -103.0K | -501.5K | -3.6M | ||
| Minority Interest | -1.3M | 0.00 | 0.00 | 0.00 | ||
| Preferred Dividend | -5.6M | -9.8M | 0.00 | -1.9M | ||
| Net Income | -47.4M | -53.3M | -40.0M | -46.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.6M | 2.2M | 3.0M | 4.9M | |
| Shares To Calculate EPS Diluted | 2.6M | 2.2M | 3.0M | 4.9M | ||
| Earnings Per Share | EPS | -$20.29 | -$29.36 | -$14.40 | -$9.76 | |
| EPS Diluted | -$20.29 | -$29.36 | -$14.40 | -$9.74 | ||
